ISRCTN89479536
Completed
Not Applicable
A prospective randomised trial of magnetic resonance imaging versus endoscopic retrograde cholangiopancreatography evaluation of patients with suspected cholelithiasis
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites168 target enrollmentSeptember 12, 2003
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cholelithiasis
- Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Enrollment
- 168
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Total number of subjects \= 168\.
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
tility of Magnetic Resonance Imaging in Lower Rectal CancerHealth Condition 1: K55-K64- Other diseases of intestinesCTRI/2018/09/015705Syed Nusrath
Completed
Not Applicable
Investigating Magnetic Seizure Therapy in Major Depressive Disorder.ACTRN12611000054910Professor Paul Fitzgerald40
Completed
Not Applicable
Electromagnetictherapy for treatment of insomniaprimary insomnia.A condition of unsatisfactory quantity and/or quality of sleep, which persists for a considerable period of time, including difficulty falling asleep, difficulty staying asleep, or early final wakening. Insomnia is a common symptom of many mental and physIRCT201112128382N1Ardebil University Of Medical Sciences60
Recruiting
Not Applicable
Verification of the usefulness of magnetic resonance imaging (MRI) to confirm the improvement of comorbidities before/after bariatric surgeryEndocrine, nutritional and metabolic diseasesKCT0009704Gachon University Gil Medical Center80
Active, not recruiting
Not Applicable
MAGNET - a randomised placebo controlled trial of the use of nebulised magnesium sulphate in moderate/severe acute asthma in childhood - MAGNETMAGNET is a randomised placebo(isotonic saline) controlled trial of the use of nebulised magnesium sulphate in moderate/severe acute asthma in childhood. All children (2-16 years of age) presenting to the paediatric assessment unit or the emergency unit at the University Hospital of Wales with severe asthma will be eligible for the study.EUCTR2004-003825-29-GBCardiff and Vale NHS Trust20